Stella Bulengo
Dermatology · San Antonio, TXNPI 1194717447
Payments from drug & device makers
Across 94 payments — averaging $33.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medimetriks Pharmaceuticals, Inc.$500
- AbbVie$447
- UCB, Inc.$252
- Janssen Scientific Affairs, LLC$252
- Galderma Laboratories, L.p.$208
- Helsinn Therapeutics (U.S.), Inc.$174
- plus $1K from 23 others
What the payments were for
- Consulting fees$50016%
- Food & beverage$2,68684%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | 1 | $500 |
| AbbVie | 21 | $447 |
| UCB, Inc. | 7 | $252 |
| Janssen Scientific Affairs, LLC | 3 | $252 |
| Galderma Laboratories, L.p. | 7 | $208 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $174 |
| Lilly USA, LLC | 3 | $172 |
| Boehringer Ingelheim | 2 | $142 |
| Chiesi USA, Inc. | 1 | $130 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $128 |
| Pfizer | 7 | $105 |
| Novartis | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 5 | $93 |
| Krystal Biotech Inc | 3 | $73 |
| Mayne Pharma Commercial LLC | 3 | $60 |
| Sanofi | 3 | $56 |
| Sun Pharmaceutical Industries Inc. | 3 | $53 |
| Biofrontera Inc. | 2 | $37 |
| Amgen | 2 | $32 |
| Arcutis Biotherapeutics, Inc. | 1 | $26 |
| LEO Pharma Inc. | 2 | $25 |
| Almirall LLC | 2 | $23 |
| Incyte Corporation | 1 | $23 |
| Bristol Myers Squibb | 1 | $16 |
| Nobelpharma America, LLC | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Organon | 1 | $10 |
| Prugen, Inc. Pharmaceuticals | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Genadur$500
- Ketodan$500
- Neo-Synalar$500
- Sumadan Wash$500
- Tremfya$233
- VALCHLOR$174
- Bimzelx$136
- FILSUVEZ$130
- SPEVIGO$122
- DUOBRII$100
How this compares
$3,186 in reported general payments places this provider in the 40th percentile of 1,098 dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 31 | $5,003 |
| Fluorouracil | 23 | $1,578 |
| Ketoconazole | 57 | $1,342 |
| CiclopiroxCiclopirox Olamine | 26 | $587 |
| Clindamycin Phosphate | 12 | $301 |
| Mupirocin | 28 | $175 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Antonio
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Emily BeckerSan Antonio$2.4M
- William CragunSan Antonio$2.3M
- Steven DavisSan Antonio$1.8M
- Lindsey FinkleaSan Antonio$1.2M
- Stephen MillerSan Antonio$389K
- Vivian BucaySan Antonio$241K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.